Article Information
- Received October 19, 2017
- Revision received March 1, 2019
- Accepted March 26, 2019
- First published April 4, 2019.
- Version of record published June 12, 2019.
Author Information
Author contributions
Author contributions: M.A.B., M.C.H., and M.J.T. designed research; M.A.B., M.C.H., A.J.A., A.M., A.E.I., C.E.S., K.A.S., E.B.L., and S.R.E. performed research; M.A.B., M.C.H., A.J.A., A.M., A.E.I., and E.B.L. analyzed data; M.A.B., M.C.H., and M.J.T. wrote the paper; M.J.T. edited the paper.
↵*M.A.B. and M.C.H. contributed equally to this work.
Disclosures
- Received October 19, 2017.
- Revision received March 1, 2019.
- Accepted March 26, 2019.
This work was supported by National Institute on Drug Abuse Grants R01 DA019666, K02 DA035459, and R01 DA041808 to M.J.T., K99 DA038706 to M.C.H., and T32 DA007234 to A.E.I. and S.R.E. Behavioral studies were supported by the University of Minnesota Mouse Behavior Core, with funding from the National Institute for Neurological Disorders and Stroke P30 NS062158 to M.A.B. and M.J.T. We thank the MnDRIVE Optogenetics Core at the University of Minnesota for providing invaluable technical support for the neuromodulation studies.
The authors declare no competing financial interests.
- Correspondence should be addressed to Mark J. Thomas at tmhomas{at}umn.edu
Other Version
- previous version (April 04, 2019).
- You are viewing the most recent version of this article.
Online Impact